Genomic and nuclear organizational changes in chemotherapy-resistant rhabdomyosarcoma cells |
Ann & Robert H. Lurie Children’s Hospital of Chicago / Kyle MacQuarrie, MD/PhD |
'A' Award Grants |
2023 |
Illinois |
Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1 |
Northwestern University (Illinois) / Zibo Zhao, PhD |
Young Investigator Grants |
2018 |
Illinois |
An Oncolytic Herpes Simplex Virus Restricted in Entry to Neuroblastoma Cells |
Northwestern University Medical School / Richard Longnecker, PhD |
Innovation Grants |
2013 |
Illinois |
DNA Methylation Inhibitor Therapy for Testicular Germ Cell Tumors |
University of Illinois, Urbana-Champaign / Michael Spinella, Ph.D. |
Reach Grants |
2014 |
Illinois |
Theranostics in Children and Young Adults |
University of Iowa / Sue O'Dorisio, MD, PhD |
Springboard Grants |
2013 |
Iowa |
Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma |
University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD |
Young Investigator Grants |
2014 |
Hawaii |
DFMO-based combination therapy for the treatment of advanced stage neuroblastoma.
|
Cancer Research Center of Hawaii / Dana-Lynn Koomoa |
Young Investigator Grants |
2009 |
Hawaii |
The YB1 Way of Surviving Radiation, Pediatric Brain Tumor Resistance and Recurrence |
Emory University / Abhinav Dey, PhD |
Young Investigator Grants |
2015 |
Georgia |
PI-3 kinase as a novel and attractive target in pediatric cancer and neuroblastoma
|
Emory University / Donald Durden |
Innovation Grants |
2008 |
Georgia |
Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies |
Emory University / Christopher Porter, MD |
Innovation Grants |
2019 |
Georgia |